数学模型提示,当前 CAR-巨噬细胞剂量对低预输注肿瘤负荷有效,但对高肿瘤负荷难治
Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden.
共 4 条
MEMBER ACCOUNT
登录成功会直接打开下一页。